Keyphrases
Prostate Cancer
94%
Transforming Growth Factor-β
32%
Radical Prostatectomy
27%
Prostate
24%
Inflammatory Bowel Disease
22%
Renal Cell Carcinoma
22%
Tumor
21%
Active Surveillance
21%
Prostate-specific Antigen
20%
Bladder Cancer
19%
Radical Cystectomy
16%
Confidence Interval
16%
Prostate Cancer Screening
15%
Advanced Prostate Cancer
15%
Infectious Complications
13%
Medicaid Expansion
13%
Time-to-treatment
13%
Randomized Controlled Trial
13%
Tumor Size
13%
Muscle-invasive Bladder Cancer
11%
Nephrectomy
11%
Activin Type II Receptor
10%
Patient-Reported Outcomes Measurement Information System (PROMIS)
10%
National Surgical Quality Improvement Program (NSQIP)
10%
Growth Factor Signaling
10%
Radical Nephrectomy
10%
Quality of Life
10%
Prostate-specific Antigen Level
10%
Metastatic Renal Cell Carcinoma (mRCC)
9%
Partial Nephrectomy
9%
Sexual Behavior
9%
Testicular Cancer
9%
Prostate Radiotherapy
9%
Symptom Burden
9%
Apoptosis
9%
Renal Carcinoma Cells
9%
Progression-free Survival
9%
NCCN Guidelines
9%
Health-related Quality of Life
9%
Preneoplastic Changes
9%
CD8+ T Cells
9%
Urological Surgery
9%
Ureter
9%
Cognitive Behavioral Stress Management
9%
Bladder
8%
Non-seminomatous Germ Cell Tumor (NSGCT)
8%
Cisplatin
8%
Radiotherapy
7%
Chemotherapy
7%
Orchiectomy
7%
Medicine and Dentistry
Prostate Cancer
100%
Clear Cell Renal Cell Carcinoma
30%
Neoplasm
30%
Prostate Specific Antigen
28%
Malignant Neoplasm
28%
Prostatectomy
25%
Cystectomy
22%
Diseases
21%
Bladder Cancer
19%
Inflammatory Bowel Disease
18%
Biopsy Technique
16%
Chemotherapy
14%
Tumor Thrombus
14%
Infectious Complication
13%
Cancer Growth Factor
13%
Transitional Cell Carcinoma
13%
Metastatic Carcinoma
13%
Radical Nephrectomy
12%
Nephrectomy
11%
Cancer Diagnosis
10%
Surgery
10%
Postoperative Complication
10%
Retroperitoneal Lymph Node Dissection
10%
Partial Nephrectomy
9%
Muscle Invasive Bladder Cancer
9%
Cancer Cell
9%
Bladder
9%
Survival Rate
9%
Recurrent Disease
9%
Urologic Surgery
9%
Kidney Metastasis
9%
Time to Treatment
9%
Progression Free Survival
9%
Cancer Screening
9%
Inferior Vena Cava
9%
Quality of Life
8%
Prostate Biopsy
8%
Alternative Complement Pathway C3 C5 Convertase
8%
Orchiectomy
8%
Non Seminomatous Germinoma
8%
Operation Duration
8%
Urinary Tract Infection
7%
Cisplatin
7%
Infection
7%
Dentigerous Cyst
7%
Cancer Therapy
7%
Urinary System
7%
Gleason Score
6%
Epithelial Cell
6%
Testis Cancer
6%